Mutation status of somatic EGFR and KRAS genes in Chinese patients with prostate cancer (PCa).
about
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancersMutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients.Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population.Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.
P2860
Mutation status of somatic EGFR and KRAS genes in Chinese patients with prostate cancer (PCa).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Mutation status of somatic EGF ...... ts with prostate cancer (PCa).
@en
Mutation status of somatic EGFR and KRAS genes in Chinese patients with prostate cancer
@nl
type
label
Mutation status of somatic EGF ...... ts with prostate cancer (PCa).
@en
Mutation status of somatic EGFR and KRAS genes in Chinese patients with prostate cancer
@nl
prefLabel
Mutation status of somatic EGF ...... ts with prostate cancer (PCa).
@en
Mutation status of somatic EGFR and KRAS genes in Chinese patients with prostate cancer
@nl
P2093
P2860
P1433
P1476
Mutation status of somatic EGF ...... ts with prostate cancer (PCa).
@en
P2093
Donghao Shang
Jianming Ying
Jimao Zhao
P2860
P2888
P304
P356
10.1007/S00428-014-1566-X
P577
2014-03-05T00:00:00Z